Product NDC: | 55111-525 |
Proprietary Name: | Tacrolimus |
Non Proprietary Name: | Tacrolimus |
Active Ingredient(s): | .5 mg/1 & nbsp; Tacrolimus |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-525 |
Labeler Name: | Dr. Reddy's Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090509 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100514 |
Package NDC: | 55111-525-78 |
Package Description: | 10 BLISTER PACK in 1 CARTON (55111-525-78) > 10 CAPSULE in 1 BLISTER PACK (55111-525-79) |
NDC Code | 55111-525-78 |
Proprietary Name | Tacrolimus |
Package Description | 10 BLISTER PACK in 1 CARTON (55111-525-78) > 10 CAPSULE in 1 BLISTER PACK (55111-525-79) |
Product NDC | 55111-525 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Tacrolimus |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100514 |
Marketing Category Name | ANDA |
Labeler Name | Dr. Reddy's Laboratories Limited |
Substance Name | TACROLIMUS |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |